Abstract
Mask wearing is integral to reducing the spread of SARS-CoV-2. Information on prevalence of face mask usage is required both to model disease spread and to improve compliance with mask usage through targeted messaging. We sought to (1) estimate the prevalence of mask usage in the most populous county of Vermont (Chittenden County; > 25% of state population) and to (2) assess the effect of age and sex on mask use. We monitored the entrances to eight different business types and visually assessed individuals’ age, gender, and mask use from a distance. We collected 1004 observations from 16 May through 30 May 2020 as businesses began to reopen following an extended state-wide lock down. We analyzed these data using a Bayesian random effects logistic regression model. We found that overall 75.5% of individuals used a mask with significant effects of age and gender on mask usage. Females were more likely to wear masks than males (83.8%, n=488 vs. 67.6%, n=516 mask usage, respectively); the odds of a male wearing a mask was 53% that of the female odds. Across age groups, the elderly were most likely to wear a mask (91.4%, n=209) followed by young adults (74.8%, n=246), middle-aged adults (70.7%, n=519) and children (53.3%, n=30). The odds of an elderly person wearing a mask were 16.7 times that of a child, while the odds for young adults and middle-aged adults were ∼3 times greater than a child. Highest mask usage was in elder females (96.3%, n=109) and lowest mask usage was in male children (43.8%, n=16).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our study was purely observational without any interaction with human subjects. According to our university IRB guidelines, IRB approval was not required for an observational study (https://www.uvm.edu/rpo/determine-if-project-requires-irb-review). A request for an exemption was also made.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.